Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Are PALB2 mutations associated with increased risk of male breast cancer?

Literature DB >> 20091115

Are PALB2 mutations associated with increased risk of male breast cancer?

A Sauty de Chalon, Z Teo, D J Park, F A Odefrey, J L Hopper, M C Southey.

Abstract

Entities: Disease Gene Mutation

Mesh：

Substances：

Year: 2009 PMID： 20091115 DOI： 10.1007/s10549-009-0673-x

Source DB: PubMed Journal: Breast Cancer Res Treat ISSN： 0167-6806 Impact factor: 4.872

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.

Authors: Yuan Chun Ding; Linda Steele; Chih-Jen Kuan; Scott Greilac; Susan L Neuhausen
Journal: Breast Cancer Res Treat Date: 2010-10-07 Impact factor: 4.872

2. Strictly defined familial male breast cancer.

Authors: Uwe Güth; Dieter Müller; Dorothy Jane Huang; Ellen Obermann; Hansjakob Müller
Journal: Fam Cancer Date: 2011-03 Impact factor: 2.375

3. PALB2 mutations in German and Russian patients with bilateral breast cancer.

Authors: Natalia Bogdanova; Anna P Sokolenko; Aglaya G Iyevleva; Svetlana N Abysheva; Magda Blaut; Michael Bremer; Hans Christiansen; Margret Rave-Fränk; Thilo Dörk; Evgeny N Imyanitov
Journal: Breast Cancer Res Treat Date: 2010-12-17 Impact factor: 4.872

Are PALB2 mutations associated with increased risk of male breast cancer?

1. Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.

2. Strictly defined familial male breast cancer.

3. PALB2 mutations in German and Russian patients with bilateral breast cancer.

4. PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China.

5. Inherited and acquired alterations in development of breast cancer.

6. PALB2 and breast cancer: ready for clinical translation!

7. PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer.